Expanded Hemodialysis Therapy Market - Top Companies and Manufacturers

Companies Dominating the Expanded Hemodialysis Therapy Landscape

B. Braun Melsungen AG
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Asahi Kasei Corporation
Baxter International, Inc.
Fresenius Medical Care AG & Co. KGaA
Nikkiso Co., Ltd.
Nipro Corporation
NxStage Medical, Inc.
Cantel Medical Corp.
Satellite Healthcare, Inc.
MEDIVATORS, Inc.

Browse Key Market Insights with Data Illustration:

Expanded Hemodialysis Therapy Market Size, Growth Forecasts 2035

In the News

B. Braun Melsungen AG has finally acquired Intermedt Medizin & Technik GmbH which is allowing the company to complete its extensive portfolio as a systems provider for extracorporeal blood treatment (dialysis).
Asahi Kasei Corporation has obtained the approval for manufacturing and selling Cresemba Capsule 100 mg and Cresemba Intravenous Infusion 200 mg in Japan for the treatment of the fungal infections of aspergillosis, mucormycosis, and cryptococcosis.

Frequently Asked Questions (FAQ)

The major growth drivers for the market are the growing prevalence of diabetes and hypertension and increasing technological advancements to develop innovative therapies.

The market is anticipated to attain a CAGR of 5% over the forecast period, i.e., 2023-2035.

Complications and risks associated with dialysis coupled with the high cost associated with treatment are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are B. Braun Melsungen AG, Asahi Kasei Corporation, Baxter International, Inc., Fresenius Medical Care AG & Co. KGaA, Nikkiso Co., Ltd., Nipro Corporation, NxStage Medical, Inc., Cantel Medical Corp., Satellite Healthcare, Inc., MEDIVATORS, Inc., and other key players.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product, modality, end user, and by region.

The hospital segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

Expanded Hemodialysis Therapy Market - Top Companies and Manufacturers

Companies Dominating the Expanded Hemodialysis Therapy Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What are the major factors driving the growth of the expanded hemodialysis therapy market?

What would be the CAGR of expanded hemodialysis therapy market over the forecast period?

What are the challenges affecting the expanded hemodialysis therapy market growth?

Which region will provide more business opportunities for growth of expanded hemodialysis therapy market in future?

Who are the major players dominating the expanded hemodialysis therapy market?

How are the company profiles selected?

What are the segments in the expanded hemodialysis therapy market?

Which segment captures the largest market size in the end user segment in the expanded hemodialysis therapy market?